BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30477387)

  • 1. Sexual Assault and Cancer Screening Among Men and Women.
    Alcalá HE; Keim-Malpass J; Mitchell EM
    J Interpers Violence; 2021 Jun; 36(11-12):NP6243-NP6259. PubMed ID: 30477387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous impacts: adverse childhood experiences and cancer screening.
    Alcalá HE; Mitchell EM; Keim-Malpass J
    Cancer Causes Control; 2018 Mar; 29(3):343-351. PubMed ID: 29411203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender Identity Disparities in Cancer Screening Behaviors.
    Tabaac AR; Sutter ME; Wall CSJ; Baker KE
    Am J Prev Med; 2018 Mar; 54(3):385-393. PubMed ID: 29338956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral associations between prostate and colon cancer screening.
    Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
    J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with Cancer Screening Among Hopi Men.
    Batai K; Sanderson PR; Hsu CH; Joshweseoma L; Russell D; Joshweseoma L; Ojeda J; Burhansstipanov L; Brown SR; Ami D; Saboda K; Harris RB
    J Cancer Educ; 2022 Aug; 37(4):915-923. PubMed ID: 33083892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer screening among Latino subgroups in the United States.
    Gorin SS; Heck JE
    Prev Med; 2005 May; 40(5):515-26. PubMed ID: 15749133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of self-reported cancer-screening histories: a meta-analysis.
    Rauscher GH; Johnson TP; Cho YI; Walk JA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):748-57. PubMed ID: 18381468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.
    Zhang WQ; Tang SJ; Dobbs TE; Zhang L
    South Med J; 2020 Jul; 113(7):360-365. PubMed ID: 32617599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
    Vijan S; Hwang EW; Hofer TP; Hayward RA
    Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.
    Ahluwalia IB; Mack KA; Murphy W; Mokdad AH; Bales VS
    MMWR Surveill Summ; 2003 Aug; 52(8):1-80. PubMed ID: 14532868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship Between Sexual Assault History and Cervical Cancer Screening Completion Among Women Veterans in the Veterans Health Administration.
    Danan ER; Brunner J; Bergman A; Spoont M; Chanfreau C; Canelo I; Krebs EE; Yano EM
    J Womens Health (Larchmt); 2022 Jul; 31(7):1040-1047. PubMed ID: 35049381
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS).
    Bradbury BD; Brooks DR; Brawarsky P; Mucci LA
    Prev Med; 2005 Jul; 41(1):303-11. PubMed ID: 15917026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.